Oral Testimony at MAC "Listening Sessions" on LCDs/LCAs for use of CTPs in DFU/VLU

The Coalition provided oral testimony at the open public feedback sessions that each Medicare Administrative Contractor (MAC) held to collect stakeholder input on the proposed LCD "Skin Substitute Grafts/Cellular & Tissue-Based Products for the Treatment of DFU and VLU.”  Coalition testimony urged:

• consistency in the evidence that is being accepted by the MAC and transparency as to what metrics were utilized to review the evidence,
• transparency in its criteria for product coverage and requested that the MACs publish what they consider an adequate trial design and outcome to gain coverage,
• clarity on the time frame and process a manufacturer will need to undertake when submitting evidence for consideration.

The comments below were delivered to: CGS Administrators (5/16/2024); First Coast Service Options (5/23/2024); National Government Services (5/16/2024); Noridian Healthcare Solutions (J-E on 5/16/2024; J-F on 5/16/2024); Novitas Solutions (5/24/2024); Palmetto GBA (5/29/2024) and WPS Insurance Corporation (5/22/2024). 
See oral testimony